Cargando…

Particle radiotherapy for breast cancer

Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Hanguang, Okamoto, Masahiko, Ohno, Tatsuya, Li, Yang, Zhou, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467264/
https://www.ncbi.nlm.nih.gov/pubmed/37655110
http://dx.doi.org/10.3389/fonc.2023.1107703
_version_ 1785099077928615936
author Ruan, Hanguang
Okamoto, Masahiko
Ohno, Tatsuya
Li, Yang
Zhou, Yuan
author_facet Ruan, Hanguang
Okamoto, Masahiko
Ohno, Tatsuya
Li, Yang
Zhou, Yuan
author_sort Ruan, Hanguang
collection PubMed
description Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer
format Online
Article
Text
id pubmed-10467264
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104672642023-08-31 Particle radiotherapy for breast cancer Ruan, Hanguang Okamoto, Masahiko Ohno, Tatsuya Li, Yang Zhou, Yuan Front Oncol Oncology Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer Frontiers Media S.A. 2023-08-16 /pmc/articles/PMC10467264/ /pubmed/37655110 http://dx.doi.org/10.3389/fonc.2023.1107703 Text en Copyright © 2023 Ruan, Okamoto, Ohno, Li and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ruan, Hanguang
Okamoto, Masahiko
Ohno, Tatsuya
Li, Yang
Zhou, Yuan
Particle radiotherapy for breast cancer
title Particle radiotherapy for breast cancer
title_full Particle radiotherapy for breast cancer
title_fullStr Particle radiotherapy for breast cancer
title_full_unstemmed Particle radiotherapy for breast cancer
title_short Particle radiotherapy for breast cancer
title_sort particle radiotherapy for breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467264/
https://www.ncbi.nlm.nih.gov/pubmed/37655110
http://dx.doi.org/10.3389/fonc.2023.1107703
work_keys_str_mv AT ruanhanguang particleradiotherapyforbreastcancer
AT okamotomasahiko particleradiotherapyforbreastcancer
AT ohnotatsuya particleradiotherapyforbreastcancer
AT liyang particleradiotherapyforbreastcancer
AT zhouyuan particleradiotherapyforbreastcancer